Global Autologous Matrix-Induced Chondrogenesis Market expected to progress at a CAGR of 8.6% During 2017-2024

MRRSE includes new market research report “Autologous Matrix-induced Chondrogenesis Market  - Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024" to its huge collection of research reports. Autologous matrix-induced chondrogenesis (AMIC) applies bi-layer collagen membrane through microfracture surgery to fix the damage to the articular cartilage damage. The AMIC procedure is a one-step that uses the microfracturing method, which is an established first-line treatment. According to the research report, the global autologous matrix-induced chondrogenesis market was valued at US$89.71 mn in 2015 and is expected to be worth US$186.38 mn by 2024.

Request Free Sample Report - http://www.mrrse.com/sample/2495

Global Autologous Matrix-Induced Chondrogenesis Market: Scope and Methodology

This report on the global autologous matrix-induced chondrogenesis market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2014 to 2024, considering the macro and micro environmental factors. Growth rates for each segment within the global market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in this global market.

Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. Market size estimations involved in-depth study of services and product features of different types of services. Additionally, market related factors such as increasing demand for minimal invasive procedures and increasing prevalence of bone and joint disorder in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.

Collagen to Lead the Pack as its Usage Gains Value in Tissue Engineering Sector

On the basis of material the global autologous matrix-induced chondrogenesis market segmented into hyaluronic acid, collagen, polyethylene glycol (PEG), poly lactic-co-glycolic acid (PGLA) and others. Of these, the collagen segment held the largest share of this market in 2015, which was closely followed by hyaluronic acid. Collagen accounts for approximately 30% of all protein within the human body. Therefore, it is widely used for tissue engineering applications. High tensile strength and excellent handling properties of collagen are expected to drive the segment’s growth in the coming years.

Browse Full Report With TOC - http://www.mrrse.com/autologous-matrix-induced-chondrogenesis-market

Autologous Matrix-Induced Chondrogenesis Market: Segmentation

Based on the material the market has segmented into hyaluronic acid, collagen, polyethylene glycol (PEG), Poly lactic-co-glycolic acid (PGLA) and others segment. Geographically, the global market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In addition, the regions have been further segmented by major countries from each region. These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, China, Japan, India, Saudi Arabia, UAE, Brazil, and Mexico.

Autologous Matrix-Induced Chondrogenesis Market: Geographical and Competitive Dynamics

The report also profiles major players in this market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Anika Therapeutics, Inc., Arthro-Kinetics, B. Braun Melsungen AG, BioTissue AG, CartiHeal, Geistlich Pharma AG, JRI Orthopaedics Ltd., Matricel GmbH, Smith & Nephew plc and Zimmer Biomet Holdings.

The global autologous matrix-induced chondrogenesis market has been segmented as follows:

Global Autologous Matrix-Induced Chondrogenesis Market, by Material

Hyaluronic Acid
Collagen
Polyethylene Glycol (PEG)
Poly lactic-co-glycolic acid (PGLA
Others
Global Autologous Matrix-Induced Chondrogenesis Market, by Geography

North America
S.
Canada
Europe
K.
Germany
Rest of Europe
Asia Pacific
China
Japan
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Enquire About this Report - http://www.mrrse.com/enquiry/2495

About Us

Market Research Reports Search Engine (MRRSE) is an industry-leading database of defense market reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact

State Tower

90, State Street

Suite 700

Albany, NY - 12207

United States

Telephone: +1-518-730-0559

Email: sales@mrrse.com

Website: http://www.mrrse.com/

This release was published on openPR.